The Receptor Tyrosine Kinase RON and Its Isoforms as Therapeutic Targets in Ewing Sarcoma
Authors:
- Philipp BerningPBPhilipp Berning
- Carolin HennemannCHCarolin Hennemann
- Claudia TulottaCTClaudia Tulotta
- Christiane SchaeferCSChristiane Schaefer
- Birgit LechtapeBLBirgit Lechtape
- Marc HotfilderMHMarc Hotfilder
- Yassmine El GourariYGYassmine El Gourari
- Heribert JürgensHJHeribert Jürgens
- Ewa Snaar-JagalskaESEwa Snaar-Jagalska
- Georg HempelGeorg Hempel
- Uta DirksenUta Dirksen
- Jenny PotratzJPJenny Potratz
Open Access
Abstract
The receptor tyrosine kinase (RTK) RON is linked to an aggressive metastatic phenotype of carcinomas. While gaining interest as a therapeutic target, RON remains unstudied in sarcomas. In Ewing sarcoma, we identified RON among RTKs conferring resistance to insulin-like growth factor-1 receptor (IGF1R) targeting. Therefore, we explored RON in pediatric sarcoma cell lines and an embryonic Tg(kdrl:mCherry) zebrafish model, using an shRNA-based approach. To examine RON–IGF1R crosstalk, we employed the clinical-grade monoclonal antibody IMC-RON8, alone and together with the IGF1R-antibody IMC-A12. RON silencing demonstrated functions in vitro and in vivo, particularly within micrometastatic cellular capacities. Signaling studies revealed a unidirectional IGF1-mediated cross-activation of RON. Yet, IMC-A12 failed to sensitize cells to IMC-RON8, suggesting additional mechanisms of RON activation. Here, RT-PCR revealed that childhood sarcomas express short-form RON, an isoform resistant to antibody-mediated targeting. Interestingly, in contrast to carcinomas, treatment with DNA methyltransferase inhibitor did not diminish but increased short-form RON expression. Thus, this first report supports a role for RON in the metastatic progression of Ewing sarcoma. While principal molecular functions appear transferrable between carcinomas, Ewing sarcoma and possibly more common sarcoma subtypes, RON highlights that specific regulations of cellular networks and isoforms require better understanding to successfully transfer targeting strategies.Keywords
Funding Information
- Deutsche Krebshilfe (109567)
- Medizinische Fakultät, Westfälische Wilhelms-Universität Münster (16-002)
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (854.10.012)
This publication has 54 references indexed in Scilit:
- Transforming growth factor-β signalling controls human breast cancer metastasis in a zebrafish xenograft modelBreast Cancer Research, 2013
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- Neutrophil‐mediated experimental metastasis is enhanced by VEGFR inhibition in a zebrafish xenograft modelThe Journal of Pathology, 2012
- Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcomaNature Genetics, 2012
- Preliminary Efficacy of the Anti-Insulin–Like Growth Factor Type 1 Receptor Antibody Figitumumab in Patients With Refractory Ewing SarcomaJournal of Clinical Oncology, 2011
- IGF1-R signals through the RON receptor to mediate pancreatic cancer cell migrationCarcinogenesis, 2011
- Silencing of RON Receptor Signaling Promotes Apoptosis and Gemcitabine Sensitivity in Pancreatic CancersCancer Research, 2010
- The Ron receptor tyrosine kinase positively regulates angiogenic chemokine production in prostate cancer cellsOncogene, 2009
- High-resolution imaging of the dynamic tumor cell–vascular interface in transparent zebrafishProceedings of the National Academy of Sciences, 2007
- Mesenchymal Stem Cell Features of Ewing TumorsCancer Cell, 2007